Renal and metabolic effects of tempol in obese ZSF1 rats-distinct role for superoxide and hydrogen peroxide in diabetic renal injury

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1434-1444

  Rafikova, Olga ^a   Salah, Eman M ^a,b   Tofovic, Stevan P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COLLAGEN TYPE 4; HYDROGEN PEROXIDE; PEROXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HYPERTENSION; INFLAMMATION; INSULIN SENSITIVITY; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; LEAN BODY WEIGHT; LIPID PEROXIDATION; METABOLISM; NEPHRITIS; NONHUMAN; OBESE ZSF1 RAT; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT STRAIN; URINARY EXCRETION;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD PRESSURE; CATALASE; CYCLIC N-OXIDES; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY DISEASES; LEPTIN; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, ZUCKER; SPIN LABELS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 51649103541     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.014     Document Type: Article

References (52)

1. Jay D., Hitomi H., and Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40 (2006) 183-192
2. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
3. Roberts C.K., Barnard R.J., Sindhu R.K., et al. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55 (2006) 928-934
4. Li M.-J., and Shah A.M. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 14 (2003) S221-S226
5. Sindhu R.K., Koo J.R., Roberts C.K., et al. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies. Clin Exp Hypertens 26 (2004) 43-53
6. Chatterjee P.K., Cuzzocrea S., Brown P.A.J., et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 5 (2000) 658-673
7. Leach M., Frank S., Olbrich A., et al. Decline in the expression of copper/zinc superoxide dismutase in the kidney of rat with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury. Br J Pharmacol 125 (1998) 817-825
8. Mota-Filipe H., McDonald M.C., Cuzzocrea S., et al. A membrane permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12 (1999) 255-261
9. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2 alpha. Hypertension 33 (1999) 424-428
10. Beswick R.A., Zhang H., Marable D., et al. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37 (2001) 781-786
11. Nishiyama A., Yoshizumi M., Hitomi H., et al. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 15 (2004) 306-315
12. Kopkan L., Castillo A., Navar G.L., et al. Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 290 (2006) F80-F86
13. Rugale C., Delbosc S., Mimran A., and Jover B. Simvastatin reverses target organ damage and oxidative stress in angiotensin II hypertension: comparison with apocynin, tempol and hydralazine. J Cardiovasc Pharmacol 50 (2007) 293-298
14. Gregor G.S., Grimberg E.S., Basu S., et al. Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one-clip hypertensive rats. J Hypertension 24 (2006) 387-394
15. Banday A.A., Marwaha A., Tallam L.S., et al. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal domapine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes 54 (2005) 2219-2226
16. Asaba K., Tojo A., Onozato M.L., et al. Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol 49 (2007) 13-19
17. Tofovic S.P., Kusaka H., Kost C.K., et al. Renal function and structure in diabetic, hypertensive, obese ZDF × SHHF-hybrid rats. Ren Fail 22 (2000) 387-406
18. cp) rats. Kidney Int 61 (2002) 1433-1444
19. Tofovic S.P., and Jackson E.K. Animal models of the metabolic syndrome. Methods Mol Med 86 (2003) 29-36
20. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
21. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244 (1969) 6049-6055
22. Aebi H.E. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis vol. 3 (1987), VCH Verlagsgesellschaft mbH, Weinheim 273-286
23. Malencik D.A., and Anderson S.R. Dityrosine as a product of oxidative stress and fluorescent probe. Amino Acids 25 (2003) 233-247
24. Krishna M.C., Grahame D.A., Samuni A., et al. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A 89 (1992) 5537-5541
25. Yanes L., Romero D., Iliescu R., et al. Systemic arterial pressure response to two weeks of tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am J Physiol Regul Integr Comp Physiol 288 (2005) R903-R908
26. 1 rats. J Exp Pharm Ther 299 (2001) 973-977
27. {dot operator}- in Doca-salt rats. Hypertension 43 part 2 (2004) 329-334
28. Moreno J.M., Gomez I.R., Wangesteen R., et al. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats. Am J Physiol Endocrinol Metab 289 (2005) E776-E783
29. Galili O., Versari D., Satttler K.J., et al. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292 (2007) H904-H911
30. Park H., Hasegawa G., Obayash H., et al. Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type-2 diabetes and hypertension. Clin Chim Acta 374 (2006) 129-134
31. Blendea M.C., Jacobs D., Stump C.S., et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab 288 (2005) E353-E359
32. DeRubetis F.R., Carven P.A., and Melhem M.F. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metab Clin Exp 56 (2007) 1256-1264
33. Craven P.A., Melhem M.F., Phillips S.L., et al. Over-expression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50 (2001) 2114-2125
34. Deubertis F.R., Craven P.A., Melhem M.F., et al. Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53 (2004) 762-768
35. Fakhrzadeh L., Laskin J.D., Gardner, et al. Superoxide dismutase-overexpressing mice are resistant to ozone-induced tissue injury and increases in nitric oxide and tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 30 (2004) 280-287
36. Zanetti M., Zwacka R., Engelhardt J., et al. Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler Thromb Vasc Biol 21 (2001) 195-2001
37. Santilli F., Cipollone F., Mezzetti A., et al. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 36 (2004) 319-335
38. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
39. Mitchell J.B., Samuni A., Krishna M.C., et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29 (1990) 2802-2807
40. Tomohiro T., Kumai T., Sato T., et al. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Life Sci 80 (2007) 1364-1372
41. Turk H.M., Sevinc A., Camci C., et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 39 (2002) 117-122
42. 2 counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285 (2003) R827-R833
43. Malle E., Buch T., and Grone H.J. Myeloperoxidase in kidney disease. Kidney Int 64 (2003) 1956-1967
44. Yoshioka T., Ichikawa I., and Fogo A. Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2 (1991) 902-912
45. Johnson R.J., Couser W.G., Chi E.Y., et al. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79 (1987) 1379-1387
46. Rehan A., Johnson K.J., Kunkel R.G., et al. Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury. Kidney Int 27 (1985) 503-511
47. Rehan A., Johnson K.J., Wiggins R.C., et al. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 51 (1984) 396-403
48. Erdei N., Bagi Z., Edes I., et al. H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 292 (2007) H649-H656
49. Gao Y.J., and Lee R.M. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 146 (2005) 1061-1068
50. 2 leads to hypertension. Hypertnesion 42 (2003) 25-30
51. 2 counteracts the vasodilatory and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285 (2003) R827-R833
52. Gianello P., Saliez A., Bufkens X., et al. EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage. Transplantation 62 (1996) 1664-1666